| Sources | Names Used |
|---|---|
| GDSC1000 | Tivozanib |
| CTRPv2 | tivozanib |
| PharmacoGx | tivozanib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
| Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
| Pubchem: | 9911830 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBB | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | TRAK2 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | GOLGA8M | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | HMBS | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | CCR6 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | TBXA2R | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | CISH | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-09 |
| mRNA | RAB37 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | ASH2L | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-09 |
